UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or Both

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1613-1614

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of B Cells in Head and Neck Cancer

Cancers, 2021-10, Vol.13 (21), p.5383

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Immunology and Immunotherapy of Head and Neck Cancer

Frontiers in oncology, 2021-12, Vol.11, p.815763-815763

2021

Link zum Volltext

Verfügbarkeit prüfen

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.14 (12), p.1300

2021

Link zum Volltext

Verfügbarkeit prüfen

Spatial characterization and quantification of CD40 expression across cancer types

BMC cancer, 2023-03, Vol.23 (1), p.220-220, Article 220

2023

Link zum Volltext

Verfügbarkeit prüfen

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review

Viruses, 2023-11, Vol.15 (12), p.2320

2023

Link zum Volltext

Verfügbarkeit prüfen

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond

Cancers, 2023-10, Vol.15 (19), p.4905

2023

Link zum Volltext

Verfügbarkeit prüfen

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

EBioMedicine, 2022-08, Vol.82, p.104143-104143, Article 104143

2022

Link zum Volltext

Verfügbarkeit prüfen

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e004757

2022

Link zum Volltext

Verfügbarkeit prüfen

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities

Vaccines (Basel), 2022-10, Vol.10 (10), p.1673

2022

Link zum Volltext

Verfügbarkeit prüfen

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

NPJ precision oncology, 2022-12, Vol.6 (1), p.92-92

2022

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for immunotherapy response in head and neck cancer

Cancer treatment reviews, 2020-03, Vol.84, p.101977-101977, Article 101977

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non-Small Cell Lung Cancer

Clinical cancer research, 2022-01, Vol.28 (2), p.360-367

2022

Link zum Volltext

Verfügbarkeit prüfen

Digital spatial profiling to uncover biomarkers of immunotherapy outcomes in head and neck squamous cell carcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6050-6050

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6537-6537

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1143-1149

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

Oral oncology, 2020-12, Vol.111, p.105013-105013, Article 105013

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Journal of thoracic oncology, 2022-08, Vol.17 (8), p.991-1001

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives

Clinical breast cancer, 2022-10, Vol.22 (7), p.642-649

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative Oncology Group study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6556-6556

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Laboratory investigation, 2022-05, Vol.102 (10), p.1143-1149

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of an immunohistochemical assay for Siglec-15

Laboratory investigation, 2022-07, Vol.102 (7), p.771-778

2022

Link zum Volltext

Verfügbarkeit prüfen

P-78 Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142)

Oral oncology, 2021-07, Vol.118, p.3-3

2021

Link zum Volltext

Verfügbarkeit prüfen

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)

Oral oncology, 2023-04, Vol.139, p.106358-106358, Article 106358

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Oncology
(19)
Humans
(15)
Immunotherapy
(14)
Biomarkers
(9)
Head And Neck Cancer
(9)
Chemotherapy
(7)
Tumors
(7)
Apoptosis
(6)
Cancer
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(6)
Immune Checkpoint Inhibitors
(6)
Lung Cancer
(6)
Medical Prognosis
(6)
Patients
(6)
Proteins
(6)
Antibodies
(5)
B7-H1 Antigen - Metabolism
(5)
Clinical Trials
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or Both

The Role of B Cells in Head and Neck Cancer

Editorial: Immunology and Immunotherapy of Head and Neck Cancer

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy

Spatial characterization and quantification of CD40 expression across cancer types

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review

Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

Biomarkers for immunotherapy response in head and neck cancer

Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non-Small Cell Lung Cancer

Digital spatial profiling to uncover biomarkers of immunotherapy outcomes in head and neck squamous cell carcinoma

Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs)

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives

Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative Oncology Group study

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Development of an immunohistochemical assay for Siglec-15

P-78 Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142)

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)

Suchergebnisse filtern